WTV - ETF AI Analysis
Top Page
WisdomTree US Value Fund of Benef Interest (WTV)
WTV, the WisdomTree US Value Fund, earns a solid overall rating thanks to several strong, diversified holdings with healthy financial performance and long-term growth drivers. Standout positions like Salesforce, Merck, Newmont Mining, and Cisco contribute positively through robust earnings, strategic focus on AI or innovation, and generally supportive technical trends, while names such as Citigroup, Target, and Thermo Fisher introduce some caution due to mixed technical signals, valuation concerns, and specific financial challenges. The main risk factor is the fund’s exposure to potential overvaluation and bearish or volatile technical trends in several holdings, which could increase short-term price swings even though the underlying businesses are generally sound.
WTV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.34B
- Region
- North America
- Expense Ratio
- 0.12%
- Beta
- 0.78
- Issuer
- WisdomTree
- Inception Date
- Feb 23, 2007
- Dividend Yield
- 1.99%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
WTV Summary
WTV is the WisdomTree US Value Fund, an ETF that invests in a wide range of U.S. companies with a focus on value stocks—shares that appear relatively cheap based on their business strength. It does not track a specific index, but follows a value theme across many sectors like financials, technology, and health care. Well-known holdings include Nvidia and Berkshire Hathaway. Someone might invest in WTV to diversify across many U.S. value companies and seek long-term growth from stocks that may be undervalued. A key risk is that value stocks can stay out of favor and the share price can go up and down with the stock market.
How much will it cost me?
WTV has an expense ratio of 0.12%, which means you’ll pay about $1.20 per year for every $1,000 invested. That’s lower than the average ETF because it’s a rules-based, mostly passive strategy rather than a fully actively managed fund.
What would affect this ETF?
WTV focuses on U.S. value stocks across sectors like financials, technology, health care, and energy, so it could benefit if the U.S. economy stays resilient, corporate profits grow, and investor sentiment shifts toward undervalued companies, especially holdings such as Nvidia, Berkshire Hathaway, and Chevron. On the downside, a U.S. slowdown, rising interest rates that pressure financials, weaker energy prices, or company-specific setbacks in major holdings like large tech or banks could weigh on the fund’s future performance.
WTV Top 10 Holdings
WTV leans into U.S. value with a clear tilt toward financials, tech, and health care, and a roster of big, familiar names driving the story. Nvidia has been a key engine, rising steadily on the back of the AI boom, while Chevron and Merck add a sturdy mix of energy and pharma strength. Target and Thermo Fisher have also been climbing, giving the fund a lift from consumer and life sciences. On the flip side, Salesforce and Citigroup have been more mixed to lagging, occasionally acting as a brake on performance. Overall, it’s a U.S.-centric value play with a few standout growth engines under the hood.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nvidia | 3.30% | $109.02M | $5.08T | 15.97% | 76Outperform | |
| Berkshire Hathaway B | 2.72% | $89.95M | $1.16T | 11.47% | 66Neutral | |
| Chevron | 2.46% | $81.20M | $460.77B | 49.15% | 71Outperform | |
| Salesforce | 2.42% | $79.91M | $204.57B | -2.83% | 80Outperform | |
| Target | 1.85% | $61.31M | $69.40B | 57.57% | 70Neutral | |
| Newmont Mining | 1.78% | $58.74M | $113.14B | 32.41% | 81Outperform | |
| Cisco Systems | 1.77% | $58.61M | $419.89B | 56.08% | 77Outperform | |
| Merck & Company | 1.73% | $57.23M | $358.41B | 60.72% | 80Outperform | |
| Thermo Fisher | 1.72% | $56.79M | $249.14B | 19.63% | 72Outperform | |
| Citigroup | 1.51% | $49.85M | $202.33B | 22.53% | 68Neutral |
WTV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For WTV, the sentiment is Positive. The current price of 107.39 is above the 20-day moving average (MA) of 104.68, above the 50-day MA of 106.01, and above the 200-day MA of 100.61, indicating a bullish trend. The MACD of 0.45 indicates Negative momentum. The RSI at 59.62 is Neutral, neither overbought nor oversold. The STOCH value of 88.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for WTV.
WTV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $107.39 | $116.00(8.02% Upside) | $3.34B | 0.12% | 71Outperform | |
| $43.61 | $52.03(19.33% Upside) | $5.46B | 0.50% | 75Outperform | |
| $59.18 | $71.77(21.27% Upside) | $5.02B | 0.98% | 68Neutral | |
| $48.11 | $58.82(22.27% Upside) | $4.63B | 0.34% | 74Outperform | |
| $83.84 | $102.15(21.84% Upside) | $3.65B | 0.14% | 73Outperform | |
| $23.47 | $27.96(19.15% Upside) | $2.56B | 0.75% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| WTV | WisdomTree US Value Fund of Benef Interest | 107.39 | 17.39 | 19.32% | |
| QLTY | GMO U.S. Quality ETF | 43.60 | 6.01 | 15.97% | |
| AKRE | Akre Focus ETF | 59.18 | -8.14 | -12.09% | |
| TSPA | T. Rowe Price U.S. Equity Research ETF | 48.11 | 5.08 | 11.80% | |
| DCOR | Dimensional US Core Equity 1 ETF | 83.84 | 11.12 | 15.29% | |
| FTHI | First Trust BuyWrite Income ETF | 23.47 | 1.60 | 7.32% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.